Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors

INIS

• antibodies 100%
• viruses 82%
• patients 29%
• toxicity 29%
• hiv 29%
• receptors 23%
• diseases 11%
• control 11%
• capacity 5%
• in vitro 5%
• adults 5%
• production 5%
• plasma 5%
• elisa 5%
• natural killer cells 5%
• dilution 5%

Neuroscience

• Progressive Multifocal Leukoencephalopathy 88%
• JC Virus 82%
• Virus Antibody 29%
• Antibody-Dependent Cell-Mediated Cytotoxicity 29%
• Antibodies 23%
• HIV 23%
• Fc Receptor 23%
• Neutralizing Antibody 5%
• Cell Function 5%
• In Vitro 5%
• Cell Activity 5%
• Natural Killer Cell 5%
• ELISA 5%
• Human Immunodeficiency Virus Antibody 5%
• Degranulation 5%
• Glycoprotein Gp 140 5%

Immunology and Microbiology

• JC Virus 82%
• Antibody-Dependent Cell-Mediated Cytotoxicity 29%
• Virus Antibody 29%
• Human Immunodeficiency Virus 23%
• Monospecific Antibody 23%
• Fc Receptor 23%
• Antibody Titer 23%
• Effector Cell 11%
• Aptitude 11%
• ELISA 5%
• Immunocompromised Patient 5%
• Cell Function 5%
• Titer 5%
• Human Immunodeficiency Virus Antibody 5%
• Neutralizing Antibody 5%
• Degranulation 5%
• Natural Killer Cell 5%
• Viral Replication 5%
• Blood Plasma 5%
• Cell Activity 5%
• Dilution 5%
• Development 5%
• Neutralization 5%
• Time 5%